NEWS

Avrion selected as one of the top 6 Swiss start-ups in which to invest by Bilan

Bilan magazine, the influential Swiss and international business and economy publication, has selected Avrion Therapeutics as one the six best start-ups in which to invest in 2021 from a comparison of 270 new Swiss companies.
Bilan-TopStartUpstoInvest-AvrionTherapeutics
AVRION UPDATES